Chemical Compound

Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione

CAS Registry Number 27470-51-5
Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 结构式
Primary record

Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione

库存
7,848 克
纯度
99.8 %
CAS
27470-51-5

化合物标识与属性

CAS
27470-51-5
PubChem CID
5362
SMILES
CCCCC1(C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)COC(=O)CCC(=O)O
Canonical SMILES
CCCCC1(COC(=O)CCC(=O)O)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O

名称与同义词

  • suxibuzone
  • Suxibuzona
  • Calibene
  • Danilon
  • Flogos
  • Suxibuzonum
  • Solurol
  • Flamilon
  • Aflogan
  • Alfide
  • suxibutazone
  • 27470-51-5
  • Suxibuzon
  • Suxibuzone CRS
  • Prestwick_113
  • Suxibuzonum [INN-Latin]
  • Suxibuzona [INN-Spanish]
  • Suxibuzone [INN:JAN]
  • Suxibuzone (Standard)
  • 86TDZ5WP2B
  • Spectrum_000321
  • 4-Hydroxymethylbutazolidine hemisuccinate
  • UNII-86TDZ5WP2B
  • AE-17
  • DTXSID6021296
  • Suxibuzone (JAN/INN)
  • AC1Q5VSO
  • SUXIBUZONE [INN]
  • SUXIBUZONE [JAN]
  • Prestwick0_000658
  • Prestwick1_000658
  • Prestwick2_000658
  • Prestwick3_000658
  • RefChem:890070
  • Spectrum2_000966
  • Spectrum3_000664
  • Spectrum4_000433
  • Spectrum5_001113
  • C24H26N2O6
  • Suxibuzone [INN:BAN:JAN]
  • CHEBI:32173
  • Epitope ID:124941
  • AC1L1K6N
  • SUXIBUZONE [MART.]
  • DTXCID601296
  • ONWXNHPOAGOMTG-UHFFFAOYSA-N
  • AE 17
  • SUXIBUZONE [WHO-DD]
  • SCHEMBL25810
  • BSPBio_000695
  • BSPBio_002327
  • KBioGR_000786
  • KBioSS_000801
  • MLS002153938
  • DivK1c_000171
  • NSC-757866
  • SPECTRUM1501157
  • EINECS 248-477-6
  • SPBio_000971
  • SPBio_002616
  • BPBio1_000765
  • orb1710722
  • CHEMBL1414320
  • SUXIBUZONE [EP IMPURITY]
  • CTK4F9751
  • HMS500I13
  • HY-B1079R
  • KBio1_000171
  • KBio2_000801
  • KBio2_003369
  • KBio2_005937
  • KBio3_001547
  • BRD5826
  • BRN 0904563
  • CID5362
  • M02AA22
  • SUXIBUZONE [EP MONOGRAPH]
  • MFCD00079562
  • NINDS_000171
  • HMS1570C17
  • HMS1923I17
  • HMS2097C17
  • HMS2232E17
  • HMS3371A12
  • HMS3714C17
  • HMS5083M15
  • Pharmakon1600-01501157
  • 4-((4-Butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy)-4-oxobutanoic acid
  • BRD-5826
  • CID:5362
  • HY-B1079
  • ZINC3875039
  • Tox21_110615
  • Tox21_202352
  • Tox21_302778
  • AR-1F9199
  • CCG-40180
  • NCGC00016799-01
  • NSC757866
  • AKOS024374988
  • C24-H26-N2-O6
  • Tox21_110615_1
  • 4-[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid
  • CS-4635
  • DB13232
  • NSC 757866
  • CAS-27470-51-5
  • IDI1_000171
  • NCGC00016799-02
  • NCGC00016799-03
  • NCGC00016799-04
  • NCGC00016799-05
  • NCGC00016799-06
  • NCGC00016799-08
  • NCGC00095261-01
  • NCGC00095261-02
  • NCGC00095261-03
  • NCGC00095261-04
  • NCGC00256470-01
  • NCGC00259901-01
  • J10.731J
  • MS-27855
  • SMR001233279
  • 4-Butyl-4-hydroxymethyl-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate
  • SBI-0051667.P002
  • SID:134223485
  • DB-047228
  • LS-147486
  • 4-BUTYL-4-[HYDROXYMETHYL]-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE HYDROGEN SUCCINATE [ESTER]
  • AB00052229
  • FT-0630533
  • NS00008152
  • ST51015119
  • X6836
  • D01289
  • F85232
  • AB00052229_08
  • AB00052229_09
  • 4-Butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate (ester)
  • 470S515
  • A936730
  • C003371
  • SR-01000841241
  • Q7650623
  • SR-01000841241-2
  • SR-01000841241-3
  • BRD-K78815826-001-05-4
  • BRD-K78815826-001-08-8
  • BRD-K78815826-001-13-8
  • BRD-K78815826-001-14-6
  • Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione
  • 1,2-Diphenyl-4-n-butyl-4-hydroxymethyl-3,5-dioxopyrazolidine Hemisuccinate
  • 4-Butyl-4-(beta-carboxypropionyl-oxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione
  • 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione
  • 3,5-Pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrogen succinate (ester)
  • 3-((4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methoxycarbonyl)propionsaeure
  • Suxibuzone, European Pharmacopoeia (EP) Reference Standard
  • 4-{[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl]oxy}-4-oxobutanoic acid
  • 4-BUTYL-4-[HYDROXYMETHYL]-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONEHYDROGENSUCCINATE[ESTER]
  • Butanedioic acid, mono((4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl) ester
  • Butanedioic acid, mono[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester
  • 28277-71-6
  • 3-(1,2-Diphenyl-3,5-dioxo-4-butylpyrazolidine-4-ylmethoxycarbonyl)propionic acid
  • 4-[(4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methoxy]-4-oxobutanoic acid
  • 4-[(4-butyl-3,5-dioxo-1,2-diphenyl-pyrazolidin-4-yl)methoxy]-4-oxo-butanoic acid
  • 4-Butyl-4-(.beta.-carboxypropionyl-oxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione
  • Butanedioic acid mono-nu[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester
  • Butanedioic acid,1-[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester
  • Succinic acid hydrogen (1,2-diphenyl-3,5-dioxo-4-butylpyrazolidin-4-yl)methyl ester
  • Succinic acid hydrogen (4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl ester
  • Succinic acid hydrogen 1-[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester
  • succinic acid monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione
  • Suxibuzone; 4-[(4-Butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid
  • 248-477-6
  • 3-{[(4-butyl-3,5-dioxo-1,2-diphenyl-1,2-diazolidin-4-yl)methyl]oxycarbonyl}pro panoic acid
  • SB